chevron_leftBack
As of 10 June 2026, Inventera Inc. has a market cap of $118.02M USD, ranking #24382 globally and #1119 in South Korea.
It ranks #2180 in the Healthcare sector, and #419 in the Biotechnology industry.
Key Stats
Market Cap
$118.02MUSD
180.12B KRW
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Tae-Hyun Shin
open_in_new
Founded
2018
Website
inventera.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 12% | -45% | -73% | -73% | -73% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
0007J0
ISIN: KR70007J0006
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
22,900 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Inventera Inc.
Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI. The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.68B
38K%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$28.01B
24K%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.32B
11K%
20.33T KRW
|
146.6
|
|
KRX: 028300
|
$5.49B
5K%
8.37T KRW
|
-
|
|
KRX: 087010
|
$3.98B
3K%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.24B
2K%
3.42T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
154K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
135K%
|
19.0
|
|
EBR: ARGX
|
$47.72B
40K%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$42.39B
36K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.26B
36K%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
23K%
|
-
|
chevron_leftBack